Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma

Acta Oto-Laryngologica

Volumn 128, Issue 3, 2008, Pages 324-328

  Prades, J M ^a   Timoshenko, A P ^a   Schmitt, Th ^a   Delolme, M P ^a   Francoz, M ^a   Martin, C ^a   Saban Roche, L ^a   Martin, Ch ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

Author keywords

Cervical nodal metastasis; Chemoradiotherapy; Head and neck cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PIRIFORM RECESS CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 39349093990     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701477669     Document Type: Article

References (20)

1. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects and limitations. Arch Otolaryngol Head Neck Surg 2004;130:861-7.
2. Stenson KM, Haraf DJ, Pelzer H, Recant W, Kies MS, Weichselbaum RR, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-6.
3. Robbins KT, Wong FSH, Kumar P, Hartsell WF, Vieira F, Mullins B, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-5.
4. Wang SJ, Wang MB, Yip H, Calcaterra TC. Combined radiotherapy with planned neck dissection for small head and neck cancers with advanced cervical metastases. Laryngoscope 2000;110:1794-7.
5. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservations in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
6. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
7. Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-55.
8. McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-8.
9. Lavertu P, Adelstein DJ, Saxton JP, Secic M,Wanamaker JR, Eliachar I, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-66.
10. Ha PK, Couch ME, Tufano RP, Koch WM, Califano JA. Short hospital stay after neck dissection. Otolaryngol Head Neck Surg 2005;133:677-80.
11. Proctor E, Robbins KT, Vieira F, Hanchett C, Sommes G. Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck 2004;26:272-7.
12. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
13. Smith RV, Goldman Y, Beitler JJ, Wadler SS. Decreased short and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:831-6.
14. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52.
15. Wanebo H, Chougule P, Ready N, Safran H, Ackerley W, Koness RJ, et al. Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001;8:644-50.
16. Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:526-31.
17. Pellitteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2006;28:166-75.
18. Brkovich SV, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006;116:855-8.
19. Vergeer MR, Doornaert P, Leemans CR, Buter J, Slotman BJ, Langendijk JA. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 2006;79:39-44.
20. Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418-23.